spacer
Leftshadow
Main flash area
Welcome
COMPANY PROFILE | BOARD OF DIRECTORS | ADVISORY BOARD | EXECUTIVE OFFICERS | MEMBERSHIPS & AFFILIATIONS
BOARD OF DIRECTORS
 
L Siebert Lawrence A. Siebert
President and Director  

Mr. Siebert has been Chairman of Chembio Diagnostic Systems, Inc. since 1992 and its President since mid-2002.  Mr. Siebert’s  background is in private equity and venture capital investing.  From 1982 to 1991, he was associated with Stanwich Partners, Inc, which during that period financed and invested in middle market manufacturing and distribution companies.  From 1992 to 1999, Mr. Siebert was an investment consultant and business broker with Siebert Capital Corp. and Siebert Associates LLC and was a principal investor in a privately held test and measurement company which was sold in 2002.  Mr. Siebert received a JD from Case Western Reserve University School of Law in 1981 and a BA with Distinction in Economics from the University of Connecticut in 1978.

 
     
G Meller Gary Meller, MD MBA
Director

Dr. Meller was elected to Chembio’s Board of Directors on March 15, 2005. Since 2001, he has been the president of CommSense Inc., a healthcare business development company.  CommSense Inc. works with clients in Europe, Asia, North America, and the Middle East regarding medical information technology, medical records, pharmaceutical product development and financing, health services operations and strategy, and new product and new market development.  From 1999 until 2001 Dr. Meller was the executive vice president, North America, of NextEd Ltd., a leading internet educational services company in the Asia Pacific region.  He is  also a member of the Advisory Board of Crestview Capital Master LLC, which was the lead investor in Chembio’s series B preferred stock private placement. Dr. Meller is a graduate of the University of New Mexico School of Medicine and has an MBA from the Harvard Business School.
 
     
K Davis Katherine L. Davis
Director

Katherine Davis was nominated to serve on the Board of Directors on May 10, 2007.  Ms. Davis is presently the owner of Davis Design Group LLC, a company that provides analytical and visual tools for public policy design.  Previously she served as the Chief Executive Officer of Global Access Point, a start up company with products for data transport, data processing, and data storage network and hub facilities.  From October 2003 to January 2005 Ms. Davis was Lieutenant Governor of the State of Indiana, and from January 2000 to October 2003 was Controller of the City of Indianapolis.  From 1989 to 2003 Ms. Davis held leadership positions with agencies and programs in the State of Indiana including State Budget Director, Secretary of Family & Social Services Administration, and Deputy Commissioner of Transportation. From 1982 to 1989 Ms. Davis held increasingly senior positions with Cummins Engine, where she managed purchasing, product cost, manufacturing, engineering, and assembly of certain engine product lines.  Ms. Davis serves on the not-for-profit boards of Noble of Indiana, Indiana Museum of African American History, University of Evansville Institute of Global Enterprise, and Purdue College of Science Dean's Leadership Council. She has a Masters of Business Administration from Harvard Business School and a Bachelor Science in Mechanical Engineering from the Massachusetts Institute of Technology.
 
     
  James D. Merselis
Director

James D. Merselis was elected to the Company’s Board of directors on March 20, 2008. From 2002 through 2007 Mr. Merselis was President, CEO and a director of HemoSense, Inc., a point-of-care diagnostic company focused initially on blood coagulation systems for monitoring patients taking warfarin. At HemoSense, he led the Company's development from a pre-revenue, venture-backed start-up through an initial public offering and on to a successful organization selling products in more than 20 countries and a market share exceeding 25% in the U.S. professional segment. In August 2007, Mr. Merselis negotiated the sale of HemoSense to Inverness Medical Innovations. Previously he was President and CEO of Micronics, Inc., where he established key relationships with Amgen, Honeywell and Waytek, and helped transform Micronics from a research project to one focused on commercializing microfluidics tools. Earlier in his career Mr. Merselis was with Boehringer Mannheim, where he advanced through a variety of positions in the U.S. and Europe over a period of more than 20 years, lastly as Senior Vice President and Director of the Company's U.S. Laboratory Diagnostics business. Mr. Merselis holds a Bachelor of Science (Pre-Med) from Nebraska Wesleyan University and an Advanced Management Program Certificate from Harvard Business School.
 
     
 
Leftshadow
shadow shadow shadow
  Terms of Use | Privacy Policy | Trademarks | Feedback